Koen hauser biography of abraham

This journal was written for my parents in the hope that it will reach both of them in good health. Their son: Pierre Feigl. Condom, August 27, 1942

My Journal

beginning on

Thursday, August 27

Mr. Weissmann had spoken to me about it. It was before lunch that the directress, coming back from Condom, called me to her office and told me what had happened to you, my dears!¹ It was the Secours Suisse² that wrote him that they had come looking for you. I thought I would go mad. At the same time she gave me the last letter dated the twenty-fifth, with the ration coupons and 5 francs. Right away I wrote the Sternefelds, asking them to look after you, our belongings, me. I went out with the Scouts. Later I came back and went to look for the milk. I thought a lot about you while waiting for your news.

Friday, 28

I went to communion and I prayed for you, my loved ones.

Sa

•

Introduction: provenance and treatment history

1This controversial painting depicting the life-size figures of Saul and David portrayed against a dark nondescript background was acquired in 1898 by the then Mauritshuis director, Abraham Bredius. The painting was later bequeathed to the Mauritshuis in 1946 (fig. 1). Although doubts had been raised in the 19^th century about Rembrandt’s authorship, up until 1969, when Horst Gerson dismissed it from Rembrandt’s oeuvre, the picture has always been regarded as one of Rembrandt’s greatest paintings1. Since then, there fryst vatten probably no other painting that has generated such differences of opinion as to Rembrandt’s role in the painting. Remarkably, the first mention of the painting occurs in the Caraman Paris auction of 1830, where its width is listed as some 20 cm wider: “T. h. 45 p. l. 67” [= c. 121.5 x 180.9 cm] (see table). Even though the painting had been studied very thoroughly in the late 1970s, and igen in the 1990s, a number o

•

December 20, 2024

• Autoimmunity

  Systematic literature review and meta-analysis informing the EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer

  EdenSebbag, JuanMolina-Collada, RamatoulayeNdoye, DanielAletaha, JohanAskling, KarolinaGente, HeidiBertheussen, SamuelBitoun, Ertugrul CagriBolek, Maya HBuch, Gerd RBurmester, Helena MCanhão, KaterinaChatzidionysiou, Jeffrey RCurtis, Francois-XavierDanlos, VeraGuimarães, Merete LundHetland, FlorenzoIannone, MarieKostine, Tue WenzelKragstrup, Tore KKvien, Anne ConstanzeRegierer, HendrikSchulze-Koops, NathanaëlSedmak, LucíaSilva-Fernández, ZoltanSzekanecz, KimLauper, AxelFinckh, Jacques-EricGottenberg

  doi: 10.1136/ard-2024-225981

• Recommendation

  2024 EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer

  EdenSebbag, KimLauper, JuanMolina-Collada, DanielAletaha, JohanAskling, Karolin